KR102211352B1 - 제1형 당뇨병 응용을 위한 인공 췌장의 모델-기반 개인화 방식 - Google Patents

제1형 당뇨병 응용을 위한 인공 췌장의 모델-기반 개인화 방식 Download PDF

Info

Publication number
KR102211352B1
KR102211352B1 KR1020157021705A KR20157021705A KR102211352B1 KR 102211352 B1 KR102211352 B1 KR 102211352B1 KR 1020157021705 A KR1020157021705 A KR 1020157021705A KR 20157021705 A KR20157021705 A KR 20157021705A KR 102211352 B1 KR102211352 B1 KR 102211352B1
Authority
KR
South Korea
Prior art keywords
controller
insulin
model
subject
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157021705A
Other languages
English (en)
Korean (ko)
Other versions
KR20150108862A (ko
Inventor
프란시스 제이. 삼세 도일
에얄 다싸우
데일 이. 세보그
준 복 이
Original Assignee
더 리전트 오브 더 유니버시티 오브 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 리전트 오브 더 유니버시티 오브 캘리포니아 filed Critical 더 리전트 오브 더 유니버시티 오브 캘리포니아
Publication of KR20150108862A publication Critical patent/KR20150108862A/ko
Application granted granted Critical
Publication of KR102211352B1 publication Critical patent/KR102211352B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • G—PHYSICS
    • G05—CONTROLLING; REGULATING
    • G05B—CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS
    • G05B2219/00—Program-control systems
    • G05B2219/30—Nc systems
    • G05B2219/42—Servomotor, servo controller kind till VSS
    • G05B2219/42018—Pid learning controller, gains adapted as function of previous error

Landscapes

  • Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157021705A 2013-01-14 2014-01-13 제1형 당뇨병 응용을 위한 인공 췌장의 모델-기반 개인화 방식 Active KR102211352B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361751941P 2013-01-14 2013-01-14
US61/751,941 2013-01-14
PCT/US2014/011360 WO2014110538A1 (en) 2013-01-14 2014-01-13 Model-based personalization scheme of an artificial pancreas for type i diabetes applications

Publications (2)

Publication Number Publication Date
KR20150108862A KR20150108862A (ko) 2015-09-30
KR102211352B1 true KR102211352B1 (ko) 2021-02-03

Family

ID=51167293

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157021705A Active KR102211352B1 (ko) 2013-01-14 2014-01-13 제1형 당뇨병 응용을 위한 인공 췌장의 모델-기반 개인화 방식

Country Status (7)

Country Link
US (4) US10413664B2 (enExample)
EP (1) EP2943149B1 (enExample)
JP (2) JP2016506775A (enExample)
KR (1) KR102211352B1 (enExample)
AU (1) AU2014205120B2 (enExample)
CA (1) CA2897189C (enExample)
WO (2) WO2014109898A1 (enExample)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9292010B2 (en) * 2012-11-05 2016-03-22 Rockwell Automation Technologies, Inc. Online integration of model-based optimization and model-less control
WO2014109898A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Model-based personalization scheme of an artificial pancreas for type i diabetes applications
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN104749954B (zh) * 2015-02-08 2017-04-12 北京化工大学 基于内模控制策略的智能灰箱控制系统装置及控制方法
AU2016219961B2 (en) 2015-02-18 2020-07-02 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
HK1257246A1 (zh) 2016-01-13 2019-10-18 Bigfoot Biomedical, Inc. 糖尿病管理系统的用户界面
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US10307538B2 (en) 2016-01-14 2019-06-04 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
US11096624B2 (en) 2016-12-12 2021-08-24 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and systems
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11027063B2 (en) 2017-01-13 2021-06-08 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP3398558A1 (en) 2017-05-02 2018-11-07 Carlo Andretta In body perfusion system
CN116531603A (zh) 2017-05-05 2023-08-04 伊莱利利公司 生理葡萄糖的闭环控制
EP3438858A1 (en) 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
JP7133625B2 (ja) 2017-12-21 2022-09-08 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
CA3103479A1 (en) 2018-06-22 2019-12-26 Eli Lilly And Company Insulin and pramlintide delivery systems, methods, and devices
CN109116738B (zh) * 2018-09-27 2021-04-13 杭州电子科技大学 一种工业加热炉的二自由度内模控制分析方法
CN112789070A (zh) 2018-09-28 2021-05-11 英赛罗公司 人造胰腺系统的活动模式
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
KR102788429B1 (ko) 2019-05-02 2025-03-27 삼성전자주식회사 개인화된 생체 정보 보정 장치 및 방법
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4069082B1 (en) 2019-12-06 2024-06-05 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
AU2021206190A1 (en) 2020-01-06 2022-08-18 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
EP4100958A1 (en) 2020-02-03 2022-12-14 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
WO2022072618A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US12128215B2 (en) 2020-09-30 2024-10-29 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
CN112398401B (zh) * 2020-10-29 2022-03-29 上海大学 一种基于参数失配的低开关频率多步模型预测控制方法
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US12431229B2 (en) 2021-03-10 2025-09-30 Insulet Corporation Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
US20220331520A1 (en) * 2021-04-20 2022-10-20 Insulet Corporation Automatic drug delivery system for individuals with type-2 diabetes
US20220351820A1 (en) * 2021-05-01 2022-11-03 Christopher Richard Wilson Method for determining glucose-dependent insulin sensitivity factors
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
US12406760B2 (en) 2021-06-07 2025-09-02 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
WO2023070245A1 (en) * 2021-10-25 2023-05-04 Medtrum Technologies Inc. Closed-loop artificial pancreas insulin infusion control system
CN116020007B (zh) * 2021-10-25 2025-11-25 上海移宇科技股份有限公司 闭环人工胰腺胰岛素输注控制系统
CN116020006B (zh) * 2021-10-25 2025-12-23 上海移宇科技股份有限公司 闭环人工胰腺胰岛素输注控制系统
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
WO2024147928A1 (en) 2023-01-06 2024-07-11 Insulet Corporation Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088490A1 (en) 2006-12-22 2008-07-24 Medtronic Minimed, Inc. Apparatus for controlling insulin infusion with state variable feedback
US20100228110A1 (en) 2009-03-09 2010-09-09 Achilleas Tsoukalis Implantable biosensor with automatic calibration
US20100249561A1 (en) 2007-06-21 2010-09-30 University Of Virginia Patent Foundation LQG Artificial Pancreas Control System and Related Method
US20120123234A1 (en) 2009-02-26 2012-05-17 Eran Atlas Method and system for automatic monitoring of diabetes related treatments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572545B2 (en) * 2000-09-22 2003-06-03 Knobbe, Lim & Buckingham Method and apparatus for real-time control of physiological parameters
US7460130B2 (en) * 2000-09-26 2008-12-02 Advantage 3D Llc Method and system for generation, storage and distribution of omni-directional object views
US6544212B2 (en) * 2001-07-31 2003-04-08 Roche Diagnostics Corporation Diabetes management system
US8114023B2 (en) * 2006-07-28 2012-02-14 Legacy Emanuel Hospital & Health Center Analyte sensing and response system
AU2010239138B2 (en) * 2009-04-20 2016-01-21 University Of Technology, Sydney A method and system for determining a variation in a metabolic function and managing the variation accordingly
WO2010138848A1 (en) * 2009-05-29 2010-12-02 University Of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
CA2789630C (en) * 2010-02-11 2016-12-13 The Regents Of The University Of California Systems, devices and methods to deliver biological factors or drugs to a subject
US9907909B2 (en) * 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
WO2014109898A1 (en) * 2013-01-14 2014-07-17 The Regents Of University Of California Model-based personalization scheme of an artificial pancreas for type i diabetes applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008088490A1 (en) 2006-12-22 2008-07-24 Medtronic Minimed, Inc. Apparatus for controlling insulin infusion with state variable feedback
US20100249561A1 (en) 2007-06-21 2010-09-30 University Of Virginia Patent Foundation LQG Artificial Pancreas Control System and Related Method
US20120123234A1 (en) 2009-02-26 2012-05-17 Eran Atlas Method and system for automatic monitoring of diabetes related treatments
US20100228110A1 (en) 2009-03-09 2010-09-09 Achilleas Tsoukalis Implantable biosensor with automatic calibration

Also Published As

Publication number Publication date
WO2014109898A1 (en) 2014-07-17
JP6914907B2 (ja) 2021-08-04
JP2016506775A (ja) 2016-03-07
US20220105270A1 (en) 2022-04-07
US11197955B2 (en) 2021-12-14
EP2943149A1 (en) 2015-11-18
KR20150108862A (ko) 2015-09-30
US20150306314A1 (en) 2015-10-29
AU2014205120B2 (en) 2019-10-17
EP2943149A4 (en) 2016-08-17
CA2897189A1 (en) 2014-07-17
AU2014205120A1 (en) 2015-07-23
US20200078516A1 (en) 2020-03-12
EP2943149B1 (en) 2020-09-30
US12102796B2 (en) 2024-10-01
US20240366873A1 (en) 2024-11-07
US10413664B2 (en) 2019-09-17
JP2019055258A (ja) 2019-04-11
CA2897189C (en) 2017-09-05
WO2014110538A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
KR102211352B1 (ko) 제1형 당뇨병 응용을 위한 인공 췌장의 모델-기반 개인화 방식
Marchetti et al. A feedforward–feedback glucose control strategy for type 1 diabetes mellitus
Lee et al. Model-based personalization scheme of an artificial pancreas for type 1 diabetes applications
Ruiz et al. Effect of insulin feedback on closed-loop glucose control: a crossover study
Turksoy et al. Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement
US10369281B2 (en) Devices, systems and methods for adjusting fluid delivery parameters
Palerm et al. A run-to-run control strategy to adjust basal insulin infusion rates in type 1 diabetes
CN112313754A (zh) 胰岛素和普兰林肽输送系统、方法和设备
AU2018388898A1 (en) Closed loop control of physiological glucose
León-Vargas et al. Postprandial blood glucose control using a hybrid adaptive PD controller with insulin-on-board limitation
JP2012519018A (ja) 糖尿病に関連した治療を自動モニタリングする方法およびシステム
KR20150027245A (ko) 폐쇄-루프 제어기로 수동 볼러스 또는 식사 이벤트를 취급하는 방법 및 시스템
WO2005113036A1 (en) Method and apparatus for glucose control and insulin dosing for diabetics
US10456090B2 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
Asadi et al. Adaptive fuzzy integral sliding mode control of blood glucose level in patients with type 1 diabetes: In silico studies
Hassan et al. Closed loop blood glucose control in diabetics
Boiroux et al. Overnight control of blood glucose in people with type 1 diabetes
Jacobs et al. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon
Boiroux et al. Assessment of model predictive and adaptive glucose control strategies for people with type 1 diabetes
Kaveh et al. Blood glucose regulation via double loop higher order sliding mode control and multiple sampling rate
Sejersen et al. Initial titration for people with type 1 diabetes using an artificial pancreas
JP7470121B2 (ja) 患者の血糖値を調節する自動システム
El Hachimi et al. Overcoming control challenges in the artificial pancreas
El Hachimi et al. Control algorithm of artificial pancreas systems-a review
Jallon et al. Personalization of a compartmental physiological model for an artificial pancreas through integration of patient's state estimation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 5